InvestorsHub Logo
Followers 97
Posts 3956
Boards Moderated 0
Alias Born 07/31/2020

Re: DDA post# 63069

Monday, 12/20/2021 9:42:41 AM

Monday, December 20, 2021 9:42:41 AM

Post# of 63384
Correct, the best part!

In November of this year, we closed on a $23 million capital raise and concurrently listed our securities on the Nasdaq Capital Market. This is a very significant development as we are now fully funded to complete our Phase 2 trial for our lead clinical candidate, BRTX-100, for the treatment of chronic lumbar disc disease (CLDD.)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BRTX News